Premier Health Reports 2025 Second Quarter Results

Premier Health of America (TSXV: PHA) reported a decline in revenue and profitability for its second quarter ended March 31, 2025, with revenues decreasing to $27.1 million from $46.3 million in the same period last year and adjusted EBITDA falling to $0.5 million from $2.6 million. The company attributes the downturn primarily to reduced volume in Quebec and British Columbia, impacted by Quebec's Bill 10 restrictions on independent labor and service acquisition centralization by BC health authorities; the resulting net loss was $3.1 million, compared to a $1.5 million loss in Q2 2024. Interim CEO Guy Daoust stated that Premier Health is focused on cost reduction, debt management, and operational efficiency to address ongoing challenges.

Analysis

Premier Health of America (TSXV: PHA) reported a substantial downturn in its financial performance for the second quarter ended March 31, 2025. Revenues declined significantly to $27.1 million from $46.3 million year-over-year, a 41.4% decrease, while adjusted EBITDA plummeted 80.6% to $0.5 million from $2.6 million. The company's net loss consequently widened to $3.1 million from $1.5 million in the prior year's quarter. These declines were primarily attributed to reduced volumes in Quebec and British Columbia. Specifically, Quebec's Bill 10, which imposes rate caps and restrictions on independent labor, continued to impact the Per Diem segment, now diminished to approximately 4% of revenues and 5% of gross margins. In British Columbia, a service acquisition centralization effort by health authorities led to a volume reduction, although management anticipates this could eventually benefit strong service providers. In response to these challenges, Premier Health is actively implementing cost-reduction measures, including workforce reductions in Quebec and its corporate structure, termination of office leases, and a review of the cost structure in its BC subsidiary; these cost savings are reportedly on track with Q4 2024 disclosures. The company is also undergoing a strategic refocus, with the Per Diem segment becoming largely obsolete and an increased emphasis on Travel Nurse services. Furthermore, Premier Health is evaluating opportunities in the Home Care sector and rebalancing overhead costs at its SSI subsidiary, where bookings reportedly remain comparable to its 2023 acquisition levels despite recent slowdowns. The recent appointment of CFO Guy Daoust as interim CEO on March 27, 2025, oversees these efforts, with a stated short-term commitment to cost reduction, debt management, operational efficiency, and pursuing organic growth.

Key Decisions for Investors

• Investors should closely monitor the execution and tangible financial impact of Premier Health's cost-reduction initiatives and restructuring efforts in the coming quarters, particularly their effect on stemming losses and improving adjusted EBITDA.
• It is crucial to assess the company's ability to stabilize revenues and improve margins through its strategic shift towards Travel Nurse services and its potential expansion into the Home Care market, given the significant contraction of its Per Diem business.
• Careful consideration should be given to the evolving regulatory landscape, such as the ongoing impact of Quebec's Bill 10, and the competitive dynamics in British Columbia, as these external factors will continue to significantly influence PHA's operational performance and recovery prospects.